How We Mark Time and How Time Marks Us
Dr. Gotlib discusses the road to approval of midostaurin for the treatment of advanced systemic mastocytosis.
A Randomized Trial in a Rare Cancer: Targeting CD30 in Cutaneous T Cell Lymphoma Yields Therapeutic Dividends
Dr. Roberts discusses a trial that looks at new therapies to be tested for the treatment of a rare cancer, cutaneous T cell lymphoma.
Dr. Becker studies clonal hematopoiesis and how somatic cells may contribute to clonal expansion and development of myeloid neoplasms with the acquisition of additional cooperating mutations.
Dr. Becker discusses an event called chromothripsis, which entails a catastrophic change of genome structure and acquisition of multiple mutations through chromosomal rearrangements, as a cause for cancer.
Dr. Becker takes a close look at implanted devices for chemotherapy testing of tumors, technological limitations, and major challenges for future development of the technology.
Dr. Becker compares ibrutinib-based therapy and FCR chemoimmunotherapy for untreated younger patients with chronic lymphocytic leukemia (CLL).
Dr. Becker discusses the origins of therapy-related myelodysplastic syndrome and/or acute myeloid leukemia.
Based largely on vector innovation, gene therapy for hematologic disorders has advanced tremendously in the past decade, with 2014 witnessing sustained improvement in selected inherited diseases.
Drs. Huang and Becker review a study suggesting that replication stress contributes to the chromosomal damage and functional decline characteristic of old HSCs.
Dr. Becker reviews a study on incorporating gene editing into certain gene therapy strategies.
Dr. Becker reviews a study that has identified a mechanism by which the microenvironment confers resistance to antibody therapy.
Dr. Pamela Becker reviews a study of a new Fms-like
tyrosine kinase 3 (FLT3) inhibitor (crenolanib) in
relapsed or refractory acute myeloid leukemia.
September-October 2017Volume 14, Issue 5
A new Compendium providing updated clinical information to "Ask the Hematologist" articles published in The Hematologist from 2010 to 2015 is now available.
AMERICAN SOCIETY OF HEMATOLOGY
2021 L Street NW, Suite 900, Washington, DC 20036
Phone 202-776-0544 | Fax 202-776-0545
by American Society of Hematology